Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell CarcinomaEduard Roussel, Maarten Albersen, Enrico Checcucci et al.|European Urology Oncology|2020Cited by 50
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)Michele Marchioni, Maria Carmen Mir, Maximilian C. Kriegmair et al.|European Urology Oncology|2020Cited by 34
Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC RegistryMargaret Meagher, Ithaar Derweesh, Maria Carmen Mir et al.|Clinical Genitourinary Cancer|2022Cited by 21
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret Meagher, Ithaar Derweesh, Maria Carmen Mir et al.|Frontiers in Oncology|2023Cited by 8
Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registryMargaret Meagher, Ithaar Derweesh, M.C. Mir et al.|European Urology Open Science|2020Cited by 2